NCT06164743: A trial that was reported late by VivaVision Biotech, Inc
This trial has reported, although it was 4 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT06164743 |
|---|---|
| Title | A Phase 2, Double-masked, Randomized, Vehicle-controlled Study of VVN461 Ophthalmic Solution in Treating Post -Operative Ocular Inflammation in Subjects Undergoing Routine Unilateral Cataract Surgery |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 11, 2024 |
| Completion date | May 15, 2024 |
| Required reporting date | May 15, 2025, midnight |
| Actual reporting date | May 19, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 4 |